Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00399516 · ClinicalTrials.gov registry record · Phase 4

Effect of Pulse Width With Spinal Cord Stimulation

A Phase 4 study, sponsored by Boston Scientific Corporation.

Completed
Registry status
Phase 4
Development phase
21
Enrollment target

NCT00399516: Completed Phase 4 study, sponsored by Boston Scientific Corporation.

NCT00399516 is a Phase 4 study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 21 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00399516, a Phase 4 study, has completed, sponsored by Boston Scientific Corporation.

COMPLETED
Registry status
Phase 4
Development phase
21 participants
Enrollment target

Study Summary

The primary objective of this study is to assess the effects of varying pulse width in suprathreshold dorsal column stimulation in patients with low back pain.

Primary Outcome

Pain severity as measured by NRS quantifies pain, where 0 is "no pain" and 10 is "worst pain imaginable"

Interventions

  • DEVICE Precision

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2006-11
Est. Completion 2007-11
Phase Phase 4
Boston Scientific Corporation

280 total trials

What the finished NCT00399516 record still lists

NCT00399516 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Precision is the first listed.

NCT00399516 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00399516 about?

NCT00399516 is a clinical study titled "Effect of Pulse Width With Spinal Cord Stimulation". The primary objective of this study is to assess the effects of varying pulse width in suprathreshold dorsal column stimulation in patients with low back pain.

What is the current status of trial NCT00399516?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 21 participants. The study started on 2006-11. Estimated completion is 2007-11.

What interventions are being tested in trial NCT00399516?

The interventions under investigation include: Precision (DEVICE).

Who is sponsoring clinical trial NCT00399516?

This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00399516's enrollment target sits among peer trials

21 1742nd of 2000 higher than 248 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02447874 · 21 participants · Phase 1

    Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

  • NCT03826992 · 21 participants · Phase 1

    Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia

  • NCT04107077 · 21 participants · Phase 2

    Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

  • NCT04158635 · 21 participants · Phase 1

    Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00399516, the US trial registry maintained by the National Library of Medicine. NCT00399516 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.